Scanvio Medical Secures $150,000 in Grant Funding to Revolutionize Endometriosis Diagnosis with AI-Enhanced Ultrasound Software

Scanvio Medical is thrilled to announce that we have successfully raised $150,000 in our latest funding round, marking a significant milestone in our mission to revolutionize the diagnosis of endometriosis. Our company is dedicated to empowering healthcare professionals and improving the lives of millions of women affected by this often-overlooked condition. With our innovative AI-augmented ultrasound software, we help gynecologists deliver expert-level sonography skills, enabling faster and more accurate diagnoses. Endometriosis affects an estimated 1 in 10 women of reproductive age, yet the average time to receive a diagnosis is often measured in years. Our cutting-edge solution bridges this gap, equipping medical practitioners with the necessary tools to identify endometriosis early, ultimately leading to better treatment options and improved patient outcomes. The funds raised will be utilized for further product development, including enhancing our AI algorithms, expanding our educational resources for healthcare providers, and increasing our outreach efforts to ensure that women are aware of their diagnosis options. We are immensely grateful to our investors for their belief in our vision and their commitment to supporting women's health. Together, we can change the way endometriosis is diagnosed and treated, ensuring that women receive the care they rightfully deserve. At Scanvio Medical, we believe that every woman deserves a voice in her healthcare journey, and with this funding, we are one step closer to making that a reality.